RVX-208

apolipoprotein A-I synthesis stimulator · Resverlogix Corp

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for RVX-208, covering 2012-09-20 to 2013-06-04. Get the full timeline:

Most recent: Clinical Trial Update: ApoA-I Synthesis Stimulation and Intravascular Ultrasound for Coronary Atheroma Regression Evaluation [Phase 2]